Bifogade filer
PDF
Kurs & Likviditet
Kalender
| 2024-10-24 | Kvartalsrapport 2024-Q3 |
| 2024-07-18 | Kvartalsrapport 2024-Q2 |
| 2024-06-28 | Ordinarie utdelning HNSA 0.00 SEK |
| 2024-06-27 | Årsstämma 2024 |
| 2024-04-18 | Kvartalsrapport 2024-Q1 |
| 2024-02-02 | Bokslutskommuniké 2023 |
| 2023-10-26 | Kvartalsrapport 2023-Q3 |
| 2023-07-20 | Kvartalsrapport 2023-Q2 |
| 2023-06-15 | Ordinarie utdelning HNSA 0.00 SEK |
| 2023-06-14 | Årsstämma 2023 |
| 2023-04-20 | Kvartalsrapport 2023-Q1 |
| 2023-02-02 | Bokslutskommuniké 2022 |
| 2022-10-20 | Kvartalsrapport 2022-Q3 |
| 2022-07-19 | Kvartalsrapport 2022-Q2 |
| 2022-06-17 | Ordinarie utdelning HNSA 0.00 SEK |
| 2022-06-16 | Årsstämma 2022 |
| 2022-04-21 | Kvartalsrapport 2022-Q1 |
| 2022-02-03 | Bokslutskommuniké 2021 |
| 2021-10-21 | Kvartalsrapport 2021-Q3 |
| 2021-07-15 | Kvartalsrapport 2021-Q2 |
| 2021-05-14 | Ordinarie utdelning HNSA 0.00 SEK |
| 2021-05-12 | Årsstämma 2021 |
| 2021-04-22 | Kvartalsrapport 2021-Q1 |
| 2021-02-04 | Bokslutskommuniké 2020 |
| 2020-10-22 | Kvartalsrapport 2020-Q3 |
| 2020-07-16 | Kvartalsrapport 2020-Q2 |
| 2020-06-24 | Ordinarie utdelning HNSA 0.00 SEK |
| 2020-06-23 | Årsstämma 2020 |
| 2020-04-28 | Kvartalsrapport 2020-Q1 |
| 2020-02-06 | Bokslutskommuniké 2019 |
| 2019-10-31 | Kvartalsrapport 2019-Q3 |
| 2019-07-18 | Kvartalsrapport 2019-Q2 |
| 2019-05-23 | Ordinarie utdelning HNSA 0.00 SEK |
| 2019-05-22 | Årsstämma 2019 |
| 2019-04-29 | Kvartalsrapport 2019-Q1 |
| 2019-02-08 | Bokslutskommuniké 2018 |
| 2018-11-01 | Kvartalsrapport 2018-Q3 |
| 2018-07-19 | Kvartalsrapport 2018-Q2 |
| 2018-05-30 | Ordinarie utdelning HNSA 0.00 SEK |
| 2018-05-29 | Årsstämma 2018 |
| 2018-04-25 | Kvartalsrapport 2018-Q1 |
| 2018-02-14 | Bokslutskommuniké 2017 |
| 2017-12-22 | Extra Bolagsstämma 2017 |
| 2017-11-14 | Kvartalsrapport 2017-Q3 |
| 2017-07-20 | Kvartalsrapport 2017-Q2 |
| 2017-05-24 | Ordinarie utdelning HNSA 0.00 SEK |
| 2017-05-23 | Årsstämma 2017 |
| 2017-04-26 | Kvartalsrapport 2017-Q1 |
| 2017-02-15 | Bokslutskommuniké 2016 |
| 2016-11-21 | Extra Bolagsstämma 2016 |
| 2016-11-09 | Kvartalsrapport 2016-Q3 |
| 2016-07-21 | Kvartalsrapport 2016-Q2 |
| 2016-05-11 | Årsstämma 2016 |
| 2016-04-28 | Ordinarie utdelning HNSA 0.00 SEK |
| 2016-04-27 | Kvartalsrapport 2016-Q1 |
| 2016-02-18 | Bokslutskommuniké 2015 |
| 2015-10-28 | Kvartalsrapport 2015-Q3 |
| 2015-08-25 | Kvartalsrapport 2015-Q2 |
| 2015-04-17 | Ordinarie utdelning HNSA 0.00 SEK |
| 2015-04-16 | Årsstämma 2015 |
| 2015-04-16 | Kvartalsrapport 2015-Q1 |
| 2015-02-05 | Bokslutskommuniké 2014 |
| 2014-07-25 | Kvartalsrapport 2014-Q2 |
| 2014-06-04 | Ordinarie utdelning HNSA 0.00 SEK |
| 2014-06-03 | Årsstämma 2014 |
| 2014-03-05 | Extra Bolagsstämma 2014 |
| 2014-02-05 | Bokslutskommuniké 2013 |
| 2013-07-25 | Kvartalsrapport 2013-Q2 |
| 2013-05-07 | Ordinarie utdelning HNSA 0.00 SEK |
| 2013-05-06 | Årsstämma 2013 |
| 2013-02-07 | Bokslutskommuniké 2012 |
| 2012-09-28 | Kapitalmarknadsdag 2012 |
| 2012-07-26 | Kvartalsrapport 2012-Q2 |
| 2012-05-14 | Årsstämma 2012 |
| 2012-02-09 | Bokslutskommuniké 2011 |
| 2012-01-09 | Extra Bolagsstämma 2011 |
| 2011-07-28 | Kvartalsrapport 2011-Q2 |
| 2011-05-12 | Årsstämma 2011 |
| 2011-05-06 | Ordinarie utdelning HNSA 0.00 SEK |
| 2010-04-30 | Ordinarie utdelning HNSA 0.00 SEK |
| 2010-02-10 | Bokslutskommuniké 2009 |
| 2009-07-30 | Kvartalsrapport 2009-Q1 |
| 2009-05-12 | Kvartalsrapport 2009-Q2 |
| 2009-04-30 | Ordinarie utdelning HNSA 0.00 SEK |
| 2009-04-29 | Årsstämma 1 |
Beskrivning
| Land | Sverige |
|---|---|
| Lista | Mid Cap Stockholm |
| Sektor | Hälsovård |
| Industri | Bioteknik |
Lund, Sweden, July 31, 2023. Hansa Biopharma AB "Hansa" or the "Company", (Nasdaq Stockholm: HNSA), the pioneer enzyme technology for rare immunological conditions, today announces that the number of outstanding votes in Hansa have increased during the month of July 2023 as a result of the conversion of a total of 227,834 class C shares to a total of 227,834 ordinary shares.
The conversion was carried out by Hansa in order to deliver ordinary shares to participants in Hansa's incentive program adopted at the annual general meeting in 2020 and to secure social contributions arising as a result of the incentive program. The total number of votes in Hansa has therefore increased while the total number of shares remain unchanged.
As of today, the total number of registered and outstanding shares of Hansa amounts to 55,034,241, whereof 52,671,796 are ordinary shares and 2,362,445 are class C shares. As of today, the number of votes in Hansa amounts to 52,908,040.5, and the registered share capital amounts to SEK 55,034,241. At the time of this press release the Company holds in treasury all class C shares and 52,577 own ordinary shares.
--ENDS-
This disclosure contains information that Hansa Biopharma AB is obliged to make public pursuant to the Swedish Financial Instruments Trading Act (1991:980). The information was submitted for publication, through the agency of the contact person, on 31 July, 2023, at 08:00 CEST.
Klaus Sindahl, VP Head of Investor Relations
M: +46 (0) 709-298 269
E: klaus.sindahl@hansabiopharma.com
Stephanie Kenney, VP Global Corporate Affairs
M: +1 (484) 319 2802
E: stephanie.kenney@hansabiopharma.com